Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 49: 1353-1357, 2003; 10.1373/49.8.1353
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (44)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ford, E. S.
Right arrow Articles by Mannino, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ford, E. S.
Right arrow Articles by Mannino, D. M.
Related Collections
Right arrow Laboratory Management
Right arrow General Clinical Chemistry
Right arrow Pediatric Clinical Chemistry
Right arrow Lipids, Lipoproteins, and Cardiovascular Risk Factors
(Clinical Chemistry. 2003;49:1353-1357.)
© 2003 American Association for Clinical Chemistry, Inc.

Lipids, Lipoproteins, and Cardiovascular Risk Factors

C-reactive Protein Concentration Distribution among US Children and Young Adults: Findings from the National Health and Nutrition Examination Survey, 1999–2000

Earl S. Ford1,a, Wayne H. Giles1, Gary L. Myers2, Nader Rifai4, Paul M. Ridker5 and David M. Mannino3

1 Division of Adult and Community Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30333.
Divisions of
2 Laboratory Sciences and
3 Environmental Hazards and Health Effects, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA 30341.

4 Department of Laboratory Medicine, Children’s Hospital, Harvard Medical School, Boston, MA 02115.

5 Center for Cardiovascular Disease Prevention, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115.

aAddress correspondence to this author at: Centers for Disease Control and Prevention, 1600 Clifton Rd., MS K66, Atlanta, GA 30333. Fax 770-488-8150; e-mail esf2{at}cdc.gov.


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Background: The distribution of C-reactive protein (CRP) concentrations among children and young adults in the US is not known at present.

Methods: We used data from 3348 US children and young adults 3–19 years of age who participated in the National Health and Nutrition Examination Survey, 1999–2000, to describe the distribution of CRP concentrations, based on results obtained with a high-sensitivity latex-enhanced turbidimetric assay.

Results: The range of CRP concentrations was 0.1–90.8 mg/L (mean, 1.6 mg/L; geometric mean, 0.5 mg/L; median, 0.4 mg/L). CRP concentrations increased with age. Females 16–19 years of age had higher concentrations than males in this age range (P = 0.003). Mexican Americans had the highest CRP concentrations among the three major race or ethnic groups (P <0.001).

Conclusions: For the first time, these data describe the CRP concentration distribution among US children and young adults, based on results obtained with a high-sensitivity assay.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
Inflammation plays a role in many disease processes, and its contribution to the pathophysiology of cardiovascular disease has become better appreciated in the last decade. Many markers of inflammation exist, but C-reactive protein (CRP) concentrations are easily, accurately, and relatively inexpensively measured. CRP, an acute-phase reactant, is produced in the liver and belongs to the pentraxin family of proteins (1). This protein is very sensitive to inflammation, and its concentration can increase rapidly in response to a wide range of stimuli. In studies of adults, CRP concentrations have added to the predictive ability of more traditional risk factors for cardiovascular disease (2) and perform well when compared with other measures of inflammation.

The pathogenesis of cardiovascular disease often starts in childhood. Pathology studies of children have demonstrated the presence of early precursors of atherosclerosis, such as intimal thickening and fatty streaks (3)(4)(5). Immunologic-inflammatory cells are present in early atherosclerotic lesions of the aorta in people as young as 17 years (6). Risk factors for cardiovascular disease, such as smoking, hypertension, dyslipidemia, obesity, physical inactivity, and diabetes mellitus, also often start in childhood and track into adulthood for many (7)(8)(9). Less is known about the distribution and correlates of inflammatory markers that predict cardiovascular disease risk in children and young adults, however. CRP concentrations in children are associated with excess weight (10)(11)(12), as they are in adults. In addition, CRP is significantly related to various cardiovascular disease risk factors in children (10) and has been shown to be inversely related to antioxidant concentrations (13).

Because no studies using a high-sensitivity CRP assay have described the CRP concentrations among children and young adults in the US, our purpose was to examine data from the 1999–2000 National Health and Nutrition Examination Survey (NHANES). These data may serve as reference values for the US population 3–19 years of age.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
In 1999, the NHANES became a continuously operating survey (14). The data for this analysis are from the years 1999 and 2000. A representative sample of the noninstitutionalized civilian US population was selected by use of a stratified multistage sampling design. Trained interviewers, using a computer-assisted personal interview system, interviewed participants at home. Participants were asked to subsequently attend the mobile examination center where they were asked to complete additional questionnaires, undergo various examinations (audiometry, balance, blood pressure, body composition, body measurements, cardiovascular fitness, lower extremity disease, muscle strength, oral health, physician, and vision), and to provide biological specimens, including a blood sample. Many questionnaires and examinations were targeted at participants of different age groups. Low-income persons, adolescents 12–19 years of age, persons >=60 years, African Americans, and Mexican Americans were oversampled. For children <=15 years of age, a parent or guardian provided interview information. In the mobile examination center, children provided some of their own responses, depending on the component. The CDC gave human subjects approval to NHANES. Consent was obtained from a parent or guardian for children <18 years, and assent was also obtained from children 7–17 years of age.

CRP was measured by latex-enhanced nephelometry (N High Sensitivity CRP assay) on a BN II nephelometer (Dade Behring Inc.) at the University of Washington Medical Center (Seattle, WA). The lower limit of detection for this assay was 0.1 mg/L. Participants who had a CRP concentration below this limit were assigned a value of 0.1 mg/L. Two levels of control materials from Bio-Rad Laboratories were used for quality-control purposes, and day-to-day CVs were 4.9–7.8%. The means for the control materials were 1.67 and 3.82 mg/L for samples analyzed during an initial 9-month period and 1.84 and 3.95 mg/L for a subsequent 12-month period. The performance of this assay has been shown to be good (15).

We limited our analyses to participants who attended the mobile examination center. For this analysis, we examined the CRP concentration distribution by age, sex, and race or ethnicity (white, African-American, Mexican-American). To examine whether sex or racial or ethnic differences in CRP concentrations were independent of age, body mass index percentiles, total cholesterol concentration, systolic blood pressure (for participants >=8 years of age), and smoking behavior (for participants >=12 years of age), we performed multiple linear regression analysis after log-transforming the CRP concentrations and calculated adjusted least-square means. We used SAS 8.02 to generate percentiles of the CRP concentration distribution, using the weight obtained at the mobile examination center, and SUDAAN 8.0 to test for differences of log-transformed CRP concentration between men and women and among the three major race or ethnic groups (16).


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
A total of 5085 persons whose ages ranged from 0 to 19 years participated in NHANES 1999–2000. Of these, 3348 participants 3–19 years of age with a CRP value were included in the analyses. CRP concentrations ranged from 0.1 to 90.8 mg/L. The distribution of CRP is highly skewed. Almost 33% of participants had a CRP concentration of 0.1 mg/L.

The distributions of CRP concentration by age, sex, and race or ethnicity are presented in Table 1 . In addition, because CRP concentrations >10 mg/L may reflect an acute-phase response to infectious diseases or disorders characterized by acute inflammation, we have provided details about the CRP concentration distribution for participants with a concentration <10 mg/L in Table 2 . Generally, the geometric mean concentration of CRP increased gradually with age among both male and female participants (Fig. 1 ). Geometric mean CRP concentrations were similar among male and female participants through ~15 years of age (age 3–9 years, P = 0.304; age 10–15 years, P = 0.407), after which female participants tended to have higher geometric mean concentrations than male participants 16–19 years of age (P = 0.003). To examine whether the differences in CRP concentrations between males and females 16–19 years of age were different after adjusting for age, body mass index percentiles, total cholesterol, systolic blood pressure, and smoking behavior, we performed multiple linear regression analysis with log-transformed CRP concentration as the dependent variable and calculated least-squares-adjusted means for males and females. The least-squares-adjusted geometric mean for males was 0.5 mg/L, and that for females was 0.9 mg/L (P = 0.001).


View this table:
[in this window]
[in a new window]
  		Table 1. Percentiles of CRP concentration (mg/L) among US children and young adults 3–19 years of age, NHANES 1999–2000.


View this table:
[in this window]
[in a new window]
  		Table 2. Percentiles of CRP concentration (mg/L) among US children and young adults 3–19 years of age after exclusion of participants with concentrations >10 mg/L, NHANES 1999–2000.



View larger version (13K):
[in this window]
[in a new window]
  		Figure 1. Geometric mean CRP concentration among US children and young adults after adjustment for race or ethnicity, body mass index percentile, and total cholesterol concentration, by sex and age, NHANES 1999–2000.

{blacksquare}, males; {blacktriangleup}, females. CRP concentrations >10 mg/L were excluded.

In addition, race or ethnic differences were apparent as well. Although white and African-American participants tended to show similar CRP concentrations through the 90th percentile, Mexican-American participants showed the highest concentrations from the 50th through the 99th percentiles. Mexican Americans had the highest CRP concentrations among the three major race or ethnic groups (P <0.001). Among participants 3–19 years of age, the least-squares geometric means adjusted for age, body mass index percentiles, and total cholesterol concentration were 0.5 mg/L for Mexican-American males vs 0.4 mg/L for white males (P = 0.001) and 0.7 mg/L for Mexican-American females vs 0.5 mg/L for white females (P = 0.001). Further adjustment for systolic blood pressure among participants 8–19 years of age did not change the results.


   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
This is the first study to describe the CRP concentration distribution, based on results obtained with a high-sensitivity CRP assay, in US children and young adults. Therefore, these data provide reference intervals for US children and young adults. Children and young adults have much lower CRP concentrations than adults. As in adults, the CRP concentration distribution in children and young adults is highly positively skewed.

CRP concentration varied by age, sex, and race or ethnicity. The median CRP concentration increased with age, perhaps a little more slowly among participants <=15 years than among participants >15 years of age. CRP concentrations were similar among girls and boys except for participants 16–19 years of age, among whom females had significantly higher CRP concentrations than males. Furthermore, Mexican-American children and young adults had higher CRP concentrations than whites and African Americans. Some of these demographic differences in CRP concentrations may be attributable to differences in health status (such as the presence of disease) and presence of known correlates of CRP concentration; we therefore calculated geometric mean concentrations of CRP that were adjusted for several correlates. Although some variables were collected for all participants 3–19 years of age, other sets of variables were collected for participants 8–19 years (e.g., blood pressure) and 12–19 years (e.g., smoking behavior). In addition, other potentially relevant variables, such as socioeconomic status and oral contraceptive use among female participants 12–19 years of age were not available at the time that we conducted our analyses. Developmental stage was not assessed in the survey. We thus were unable to adjust for all relevant variables, but we did adjust for age, body mass index percentiles, smoking status, systolic blood pressure, and total cholesterol concentration and examined the differences in the adjusted geometric mean CRP concentrations among racial or ethnic groups and between males and females.

Relatively little was known about the CRP concentration distribution in children. In healthy newborns, CRP concentrations range from 0 to 4 mg/L, with a median concentration of 2 mg/L (17). Among 699 British children 11 years of age, the median CRP concentration, measured with an in-house ELISA, was 0.15 mg/L (interquartile range, 0.06–0.47) (10). In NHANES III, CRP concentrations ranged from <3.0 to 93.5 mg/L as measured with an immunoassay with limited sensitivity <3.0 mg/L intended for assessing acute inflammation (11).

The utility of measuring CRP concentration in children and young adults to assess cardiovascular disease risk remains open to speculation. Recently, researchers demonstrated that CRP concentration was associated with endothelial dysfunction and carotid intima-media thickness in children (18). A previous study of 699 British children showed that CRP concentration was associated with systolic blood pressure, diastolic blood pressure, pulse, fibrinogen concentration, factor VIIc, HDL-cholesterol concentration, triglyceride concentration, apolipoprotein B concentration, and postload insulin concentration after adjustment for age, sex, ethnicity, and town (10). Further adjustment for ponderal index (kg/m3) attenuated most of the Pearson correlation coefficients to some degree and caused some of the previously significant associations (systolic blood pressure, factor VIIc, triglyceride concentration, apolipoprotein B, and postload insulin concentration) to lose their statistical significance. Other studies have also demonstrated that excess weight is strongly associated with CRP concentration in children (10)(11). Thus, children with abnormal values for cardiovascular disease risk factors are likely to have increased CRP concentrations as well but whether useful differences in CRP concentrations to assess cardiovascular disease risk can be defined remains to be established.

CRP concentration shows substantial intraindividual variability (19). Consequently, more than one measurement may be needed to better assess a person’s true CRP status. In a recent scientific statement, the American Heart Association and CDC recommended that two CRP determinations should be made 2 weeks apart in persons who are metabolically stable and free from obvious inflammatory or infectious conditions to provide a better estimate of CRP concentration (20). Several high-sensitivity assays are in commercial use. Comparisons of some of these tests have been conducted (21)(22).

In conclusion, our results show that the median CRP concentrations in children and young adults are low, far below those that have been associated with cardiovascular disease risk among adults. In addition, little is known about how CRP concentrations may track from childhood into adulthood. In adults, Rifai and Ridker (23) have proposed that CRP concentration may be especially valuable for identifying individuals at higher risk for cardiovascular disease who have lipid concentrations within reference values. Extending this proposition to children and young adults warrants further investigation.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Du Clos TW. Function of C-reactive protein. Ann Med 2000;32:274-278.[Web of Science][Medline] [Order article via Infotrieve]
  2. Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001;103:1813-1818.[Abstract/Free Full Text]
  3. Velican C, Velican D. Coronary arteries in children up to the age of ten years. II. Intimal thickening and its role in atherosclerotic involvement. Med Interne 1976;14:17-24.[Medline] [Order article via Infotrieve]
  4. Lesauskaite V, Tanganelli P, Bianciardi G, Simoes C, Toti P, Weber G. World Health Organization (WHO) and the World Heart Federation (WHF) Pathobiological Determinants of Atherosclerosis in Youth (PBDAY) Study. Histomorphometric investigation of the aorta and coronary arteries in young people from different geographical locations. Nutr Metab Cardiovasc Dis 1999;9:266-276.[Web of Science][Medline] [Order article via Infotrieve]
  5. McGill HC, Jr, McMahan CA, Zieske AW, Sloop GD, Walcott JV, Troxclair DA, et al. Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb Vasc Biol 2000;20:1998-2004.[Abstract/Free Full Text]
  6. Millonig G, Malcom GT, Wick G. Early inflammatory-immunological lesions in juvenile atherosclerosis from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY)-study. Atherosclerosis 2002;160:441-448.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  7. Nicklas TA, von Duvillard SP, Berenson GS. Tracking of serum lipids and lipoproteins from childhood to dyslipidemia in adults: the Bogalusa Heart Study. Int J Sports Med 2002;23(Suppl 1):S39-S43.
  8. Janz KF, Dawson JD, Mahoney LT. Tracking physical fitness and physical activity from childhood to adolescence: the Muscatine Study. Med Sci Sports Exerc 2000;32:1250-1257.[Web of Science][Medline] [Order article via Infotrieve]
  9. Raitakari OT, Porkka KV, Rasanen L, Ronnemaa T, Viikari JS. Clustering and six year cluster-tracking of serum total cholesterol, HDL-cholesterol and diastolic blood pressure in children and young adults. The Cardiovascular Risk in Young Finns Study. J Clin Epidemiol 1994;47:1085-1093.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  10. Cook DG, Mendall MA, Whincup PH, Carey IM, Ballam L, Morris JE, et al. C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. Atherosclerosis 2000;149:139-150.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  11. Ford ES, Galuska DA, Gillespie C, Will JC, Giles WH, Dietz WH. C-reactive protein and body mass index in children: findings from the Third National Health and Nutrition Examination Survey, 1988–1994. J Pediatr 2001;138:486-492.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  12. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Low-grade systemic inflammation in overweight children. Pediatrics 2001;107:E13.
  13. Ford ES, Gillespie C, Ballew C, Sowell A, Mannino DM. Serum carotenoid concentrations among US children. Am J Clin Nut 2002;76:818-827.[Abstract/Free Full Text]
  14. Centers for Disease Control and Prevention. NHANES 1999–2000 public data release file documentation. Hyattsville, MD: National Center for Health Statistics.http://www.cdc.gov/nchs/about/major/nhanes/currentnhanes.htm (Accessed March 4, 2003)..
  15. Ledue TB, Weiner DL, Sipe JD, Poulin SE, Collins MF, Rifai N. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum. Ann Clin Biochem 1998;35:745-753.
  16. . Research Triangle Institute. SUDAAN user’s manual, Release 8.0 2001 Research Triangle Institute Research Triangle Park, NC. .
  17. Zilow G, Zilow EP, Burger R, Linderkamp O. Complement activation in newborn infants with early onset infection. Pediatr Res 1993;34:199-203.[Web of Science][Medline] [Order article via Infotrieve]
  18. Jarvisalo MJ, Harmoinen A, Hakanen M, Paakkunainen U, Viikari J, Hartiala J, et al. Elevated serum C-reactive protein levels and early arterial changes in healthy children. Arterioscler Thromb Vasc Biol 2002;22:1323-1328.[Abstract/Free Full Text]
  19. Kluft C, de Maat MP. Determination of the habitual low blood level of C-reactive protein in individuals. Ital Heart J 2001;2:172-180.[Medline] [Order article via Infotrieve]
  20. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, 3rd, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511.[Free Full Text]
  21. Roberts WL, Sedrick R, Moulton L, Spencer A, Rifai N. Evaluation of four automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Clin Chem 2000;46:461-468.[Abstract/Free Full Text]
  22. Roberts WL, Moulton L, Law TC, Farrow G, Cooper-Anderson M, Savory J, et al. Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2. Clin Chem 2001;47:418-425.[Abstract/Free Full Text]
  23. Rifai N, Ridker PM. Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening. Clin Chem 2001;47:28-30.[Free Full Text]



The following articles in journals at HighWire Press have cited this article:


Home page
 Psychosom. Med.Home page
M. Luciano, R. E. Marioni, A. J. Gow, J. M. Starr, and I. J. Deary
Reverse Causation in the Association Between C-Reactive Protein and Fibrinogen Levels and Cognitive Abilities in an Aging Sample
Psychosom Med, May 1, 2009; 71(4): 404 - 409.
[Abstract] [Full Text] [PDF]

Home page
 JPEN J Parenter Enteral NutrHome page
K. Putchakayala, S. Polensky, J. Fitzhugh, V. Cohran, A. Buchman, and J. Fryer
An Evaluation of the Model for End-Stage Liver Disease and Serum C-Reactive Protein as Prognostic Markers in Intestinal Failure Patients on Parenteral Nutrition
JPEN J Parenter Enteral Nutr, January 1, 2009; 33(1): 55 - 61.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
M. B. Lande, T. A. Pearson, R. P. Vermilion, P. Auinger, and I. D. Fernandez
Elevated Blood Pressure, Race/Ethnicity, and C-Reactive Protein Levels in Children and Adolescents
Pediatrics, December 1, 2008; 122(6): 1252 - 1257.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
M Rodriguez-Moran and F Guerrero-Romero
Serum magnesium and C-reactive protein levels
Arch. Dis. Child., August 1, 2008; 93(8): 676 - 680.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. L. Marcovecchio, C. Giannini, B. Widmer, R. N. Dalton, S. Martinotti, F. Chiarelli, and D. B. Dunger
C-Reactive Protein in Relation to the Development of Microalbuminuria in Type 1 Diabetes: The Oxford Regional Prospective Study
Diabetes Care, May 1, 2008; 31(5): 974 - 976.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
S. Amaral, W. Hwang, B. Fivush, A. Neu, D. Frankenfield, and S. Furth
Serum Albumin Level and Risk for Mortality and Hospitalization in Adolescents on Hemodialysis
Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 759 - 767.
[Abstract] [Full Text] [PDF]

Home page
 AMERICAN JOURNAL OF LIFESTYLE MEDICINEHome page
M. G. Flynn, B. K. McFarlin, and M. M. Markofski
State of the Art Reviews: The Anti-Inflammatory Actions of Exercise Training
American Journal of Lifestyle Medicine, May 1, 2007; 1(3): 220 - 235.
[Abstract] [PDF]

Home page
 Diabetes CareHome page
E. S. Ford, C. Li, G. Imperatore, and S. Cook
Age, Sex, and Ethnic Variations in Serum Insulin Concentrations Among U.S. Youth: Findings from the National Health and Nutrition Examination Survey 1999-2002
Diabetes Care, December 1, 2006; 29(12): 2605 - 2611.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
S. Kapiotis, G. Holzer, G. Schaller, M. Haumer, H. Widhalm, D. Weghuber, B. Jilma, G. Roggla, M. Wolzt, K. Widhalm, et al.
A Proinflammatory State Is Detectable in Obese Children and Is Accompanied by Functional and Morphological Vascular Changes
Arterioscler Thromb Vasc Biol, November 1, 2006; 26(11): 2541 - 2546.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
M. Juonala, J. S.A. Viikari, T. Ronnemaa, L. Taittonen, J. Marniemi, and O. T. Raitakari
Childhood C-Reactive Protein in Predicting CRP and Carotid Intima-Media Thickness in Adulthood: The Cardiovascular Risk in Young Finns Study
Arterioscler Thromb Vasc Biol, August 1, 2006; 26(8): 1883 - 1888.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. A. Albert and P. M Ridker
C-Reactive Protein as a Risk Predictor: Do Race/Ethnicity and Gender Make a Difference?
Circulation, August 1, 2006; 114(5): e67 - e74.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
S. D. de Ferranti, K. Gauvreau, D. S. Ludwig, J. W. Newburger, and N. Rifai
Inflammation and Changes in Metabolic Syndrome Abnormalities in US Adolescents: Findings from the 1988-1994 and 1999-2000 National Health and Nutrition Examination Surveys
Clin. Chem., July 1, 2006; 52(7): 1325 - 1330.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
P. Balagopal, D. George, H. Yarandi, V. Funanage, and E. Bayne
Reversal of Obesity-Related Hypoadiponectinemia by Lifestyle Intervention: A Controlled, Randomized Study in Obese Adolescents
J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6192 - 6197.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
S. E Cusick, J. M Tielsch, M. Ramsan, J. K Jape, S. Sazawal, R. E Black, and R. J Stoltzfus
Short-term effects of vitamin A and antimalarial treatment on erythropoiesis in severely anemic Zanzibari preschool children
Am. J. Clinical Nutrition, August 1, 2005; 82(2): 406 - 412.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
E. K. Larkin, C. L. Rosen, H. L. Kirchner, A. Storfer-Isser, J. L. Emancipator, N. L. Johnson, A. M. V. Zambito, R. P. Tracy, N. S. Jenny, and S. Redline
Variation of C-Reactive Protein Levels in Adolescents: Association With Sleep-Disordered Breathing and Sleep Duration
Circulation, April 19, 2005; 111(15): 1978 - 1984.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. Lambert, E. E. Delvin, G. Paradis, J. O'Loughlin, J. A. Hanley, and E. Levy
C-Reactive Protein and Features of the Metabolic Syndrome in a Population-Based Sample of Children and Adolescents
Clin. Chem., October 1, 2004; 50(10): 1762 - 1768.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (44)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ford, E. S.
Right arrow Articles by Mannino, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ford, E. S.
Right arrow Articles by Mannino, D. M.
Related Collections
Right arrow Laboratory Management
Right arrow General Clinical Chemistry
Right arrow Pediatric Clinical Chemistry
Right arrow Lipids, Lipoproteins, and Cardiovascular Risk Factors

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS